Reading Time: 4 minutesPlenary speaker Dr Massimo Filippi put this question to delegates on the second day of the 24th International Symposium on ALS/MND. Opening the session on
Category: Markers of Disease Progression
Reading Time: < 1 minuteMND Association funded researcher Dr Martin Turner at University of Oxford has identified a pattern of degeneration in the brains of people with MND that
Reading Time: 3 minutesYesterday’s announcement by the biotechnology company Trophos SA of the lack of effectiveness of their compound olesoxime adds to the long list of drugs that
22nd Symposium: Sydney 2011 Causes and disease mechanisms Markers of Disease Progression Models of MND Symposium
Promising news for keeping the motor neurone neighbourhood safe
Reading Time: 2 minutesThere was standing room only in the first of the dedicated scientific sessions of the Symposium last week. All had gathered to hear Prof Stan
Reading Time: 4 minutesWith the huge advances in biology, it can seem that areas such as brain scanning are relatively stagnant, but we are starting to see a
Reading Time: 2 minutesThe Opening Session theme on how the disease progresses within the Central Nervous System (CNS) continued with the presentation by Prof Stan Appel from Baylor
Reading Time: < 1 minuteIt’s been a busy couple of weeks for exciting research results! Hot on the heels of the publication of Dr Turner’s imaging study, MND Association-funded researchers
Reading Time: < 1 minuteWe are pleased to announce that the first results from the Oxford Study for Biomarkers in MND/ALS (known as BioMOx) study have been published in the
Reading Time: 2 minutesLast weekend 19 neurologists and researchers gathered in a hotel seminar room in The Netherlands to talk about building closer links across Europe. Prof Leonard